Elanco Animal Health Incorporated
ELAN
株式のランク
#1871
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces,... Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.
株価
$22.70
最終同期: 2026-10-20
時価総額
$11.34B
変化（1日）
-3.45%
変化（1年）
4.97%
国
US
取引 Elanco Animal Health Incorporated (ELAN)
カテゴリー
Healthcare
Elanco Animal Health Incorporated（ELAN）の発行済株式数
June 2026 時点の発行済株式数 499.50M
Elanco Animal Health Incorporated の最新の財務報告および株価によると、現在の発行済株式数は 499.50M です。December 2023 の終わりには、同社は 492.30M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Elanco Animal Health Incorporated（ELAN）の発行済株式数の履歴（2015 ～ 2026）
各年末時点の発行済株式数
| 年 | 発行済株式数 | 変化 |
|---|---|---|
| 2026 (TTM) | 499.50M | 1.11% |
| 2024 | 494.00M | 0.35% |
| 2023 | 492.30M | 0.82% |
| 2022 | 488.30M | 0.23% |
| 2021 | 487.20M | 10.38% |
| 2020 | 441.40M | 19.62% |
| 2019 | 369.00M | 17.63% |
| 2018 | 313.70M | -11.93% |
| 2017 | 356.20M | 0.00% |
| 2016 | 356.20M | 0.00% |
| 2015 | 356.20M | 0.00% |
類似企業や競合他社の発行済株式数
| 企業 | 発行済株式数 | 差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 380.35% |
IN
|
